New Technology– category –
-
Amazon Bio Discovery Integrates UX-Driven AI Agents and Lab Connectivity within AWS AI Drug Discovery Platform to ‘Democratize’ Drug Discovery
IntuitionLabs USA Overview Amazon Bio Discovery, an AWS-powered AI drug discovery platform, integrates UX-driven AI agents, a curated library of biology-focused AI models, and built-in lab connectivity to 'democratize' the drug discovery... -
Curtiss-Wright Details ‘Unspoken Challenges’ of Edge AI in Harsh Environments: Robust Systems Overcome Thermal, Power, and SWaP Constraints
Curtiss-Wright Defense Solutions USA Overview Curtiss-Wright Defense Solutions highlighted the 'hard problems no one talks about' in edge AI implementation, including thermal management, power consumption, bandwidth, ruggedization, lifec... -
World’s Largest Chemical Reactions Database Launched to Boost AI Drug Discovery, Revolutionizing New Drug Identification
New Scientist UK Overview The world's largest chemical reactions database has been launched to drive breakthroughs in AI drug discovery. This pioneering resource establishes a foundational base for AI-driven chemistry, promising to drama... -
Leading AI Drug Discovery Platforms Evolve from Candidate Generation to Protein Design in 2026, Driven by Eli Lilly-Insilico Medicine $2.75 Billion Partnership
The AI Journal USA Overview In 2026, AI drug discovery platforms, led by Converge Bio, Xaira Therapeutics, and Generate Biomedicines, have advanced beyond mere drug prediction to encompass candidate generation, antibody engineering, targ... -
STMicroelectronics Advances Edge AI with STM32, Enabling Real-time Processing via ST Edge AI Suite for Model Optimization and C Code Compilation
STMicroelectronics Community Switzerland Overview STMicroelectronics is enabling Edge AI directly on STM32 microcontrollers and microprocessors, delivering superior power efficiency, ultra-low latency, real-time applications, and enhance... -
Multimodal AI Expands Human-like Perception, Led by Gemini 2.5 Pro and GPT-5 Integrating Text, Image, and Audio for Next-Gen Systems
Simplilearn International Overview Multimodal AI is achieving more human-like perception by simultaneously processing inputs from diverse sources like text, images, audio, video, and sensor data, and generating multi-format outputs. Mode... -
FDA Approves First AI-Designed Drug Molecule for Phase 3 Clinical Trial in 2026, Accelerating R&D with New AI Drug Discovery Regulatory Guidance
BioNixus USA Overview In March 2026, the US FDA approved the first AI-designed drug molecule for Phase 3 clinical trials, solidifying AI drug discovery as a foundational technology in pharmaceutical R&D. Following this, on May 15th, ... -
OpenAI and Broadcom Unveil LLM-Optimized AI Chip “Jalapeño,” Significantly Outperforming State-of-the-Art in Performance per Watt
OpenAI / Broadcom USA Overview OpenAI and Broadcom have announced "Jalapeño," a custom AI chip specifically designed for Large Language Model (LLM) inference. This chip significantly surpasses current state-of-the-art products in perform... -
Leading AI Coding Agents in 2026 Comprehend Multi-File Context, Revolutionizing Development Efficiency with Autonomous Code Generation, Modification, and Debugging
Kiro USA Overview In 2026, prominent AI coding agents like Windsurf, Cline, Factory AI, Kiro, Codex CLI, Manus, and Aider are demonstrating capabilities far beyond mere code completion. They understand multi-file contexts, plan and execu... -
Microsoft Copilot Studio Advances Goal-Driven Automation with AI Agents, Surpassing Chatbots with Enhanced Reasoning, Planning, and Adaptability
Microsoft Copilot Studio USA Overview Microsoft Copilot Studio announced that AI agents are transcending the limitations of chatbots and traditional automation, enabling a shift towards proactive, goal-driven automation by integrating re...
